Innovation Pharmaceuticals Inc (IPIX)

[Areader]

Could be, hard to tell. The gist of the PR and the biggest point being underscored seemed to be that one case. When Leo is then quoted, “We don’t know of any other company, regardless of specialization, albeit small molecule, immunotherapy or other, that has published [emphasis mine] an effect like that in such a hard-to-treat disease like metastatic ovarian cancer during a Phase 1 safety trial...."

"[T]hat has published an effect like that" seems to refer to the article referenced previously in the PR, that DF wants them to get more info on, and so it seems he's referring to an article about that one case, since no other company "has published" (until now, ie DF's article) anything like that.

The additional info DF wants CTIX to gather is clearly for more general info re K ("on multiple cancer lines as demonstrated in the clinical trial"!) than that one case. But, that would make sense to me to publish as part of a clinical case report, as why publish a report in a journal on that one case without also mentioning all the potential indications, as well as "safety and pharmacological effect" of K, so docs and researchers would know it's not just a one trick pony.

Either way, word is getting out and I am thrilled to be an investor but also in some small way via my investment, a supporter of this potential game-changer for patients.